Both in Pharmaceuticals
Jazz Pharmaceuticals vs Alnylam Pharmaceuticals
Over the past year JAZZ returned +66.0% and ALNY returned −63.2%; their daily moves had a correlation of 0.09.
JAZZ +66.0% ALNY −63.2%Growth of $1, one year, split-adjusted
| Metric | JAZZ | ALNY |
|---|---|---|
| Price | $230.42 | $159.99 |
| Market cap | $14.96B | $21.43B |
| Today | +7.45% | +1.26% |
| 1 month | −2.4% | −27.2% |
| 6 months | +8.6% | −46.9% |
| Year to date | +35.5% | −59.8% |
| 1 year | +67.4% | −64.9% |
| Revenue growth (YoY) | +10.4% | +16.7% |
| Gross margin | 91.1% | 75.2% |
| Net margin | −38.9% | 148.6% |
| P/E (TTM) | 72.6× | 7.9× |
| Price / sales | 3.2× | 4.3× |
| Net cash | -$2.71B | $2.57B |
| Dividend yield | — | — |
| Volatility (60d) | 31.8% | 72.9% |
| Short % of float | 9.4% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).